**Core Concept:** Beta blockers are a class of medications used for various ocular conditions primarily by blocking the effects of adrenaline on beta receptors. Beta-1 receptors are primarily responsible for tachycardia, hypertension, and bronchoconstriction, while beta-2 receptors are involved in bronchodilation, vasodilation, and ciliary body and iris relaxation. The duration of action depends on the drug's lipophilicity, affinity for beta receptors, and its ability to penetrate the blood-retina barrier.

**Why the Correct Answer is Right:** Timolol is a highly lipophilic beta blocker with high affinity for beta-1 receptors and beta-2 receptors. It is a non-selective beta blocker that can easily cross the blood-retina barrier, leading to its prolonged action.

**Why Each Wrong Option is Incorrect:**
A. Propranolol is a non-selective beta blocker, similar to timolol, but it has a shorter duration of action due to its moderate lipophilicity and lower ability to cross the blood-retina barrier.
B. Carteolol is a selective beta-1 blocker with lower lipophilicity and less ability to penetrate the blood-retina barrier, resulting in a shorter duration of action.
C. Pindolol is a non-selective beta blocker with moderate lipophilicity and lower ability to cross the blood-retina barrier, contributing to its shorter duration of action.
D. Labetalol is a non-selective beta blocker with moderate lipophilicity and penetration ability across the blood-retina barrier, making it intermediate in duration of action.

**Clinical Pearl:** Understanding the lipophilicity, receptor affinity, and blood-retina barrier penetration is crucial for selecting the appropriate beta blocker for ocular conditions. Timolol is ideal for patients requiring long-term treatment due to its prolonged duration of action.

**Correct Answer:** B. Carteolol

Carteolol, being a selective beta-1 blocker, has a shorter duration of action compared to non-selective beta blockers like timolol, propranolol, and labetalol. Its lipophilicity is moderate, which allows for limited penetration across the blood-retina barrier, resulting in reduced ocular penetration and a shorter duration of action.